Literature DB >> 2165598

Trans-activation function of a 3' truncated X gene-cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissues.

S Takada1, K Koike.   

Abstract

To investigate the expression and transactivation function of the X gene in integrated hepatitis B virus (HBV) DNA from chronic hepatitis tissues, a series of transfectants containing cloned integrated HBV DNAs was made and analyzed for X mRNA expression and trans-activation activity by using a chloramphenicol acetyltransferase assay. Most of the integrated HBV DNAs expressed X mRNA and encoded a product with trans-activation activity in spite of the loss of the 3' end region of the X gene due to integration. From cDNA cloning and sequence analysis of X mRNA transcribed from native or integrated HBV DNA, the X protein was found to be translated from the X open reading frame without splicing. For integrated HBV DNA, transcription was extended to a cellular flanking DNA and an X gene-cell fusion transcript was terminated by using a cellular poly(A) signal. The amino acid sequence deduced from an X-cell fusion transcript indicated truncation of the carboxyl-terminal five amino acids, but the upstream region of seven amino acids conserved among hepadnaviruses was retained in the integrated HBV DNA, suggesting that this conserved region is essential for the transactivation function of the X protein. These findings support the following explanation for hepatocarcinogenesis by HBV DNA integration: the expression of a cellular oncogene(s) is transactivated at the time of chronic infection by the increasing amounts of the integrated HBV gene product(s), such as the X-cell fusion product.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2165598      PMCID: PMC54380          DOI: 10.1073/pnas.87.15.5628

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA.

Authors:  K Yaginuma; Y Shirakata; M Kobayashi; K Koike
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

2.  Multiple integration site of hepatitis B virus DNA in hepatocellular carcinoma and chronic active hepatitis tissues from children.

Authors:  K Yaginuma; H Kobayashi; M Kobayashi; T Morishima; K Matsuyama; K Koike
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

3.  Hepatitis B virus integration in hepatocellular carcinoma DNA: duplication of cellular flanking sequences at the integration site.

Authors:  K Yaginuma; M Kobayashi; E Yoshida; K Koike
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

4.  Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma.

Authors:  A Dejean; L Bougueleret; K H Grzeschik; P Tiollais
Journal:  Nature       Date:  1986 Jul 3-9       Impact factor: 49.962

5.  Nucleotide sequence of a cloned woodchuck hepatitis virus genome: evolutional relationship between hepadnaviruses.

Authors:  K Kodama; N Ogasawara; H Yoshikawa; S Murakami
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

6.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

7.  Hepatocarcinogenicity of the woodchuck hepatitis virus.

Authors:  H Popper; L Roth; R H Purcell; B C Tennant; J L Gerin
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

Review 8.  The hepatitis B virus.

Authors:  P Tiollais; C Pourcel; A Dejean
Journal:  Nature       Date:  1985 Oct 10-16       Impact factor: 49.962

9.  Complete nucleotide sequence of hepatitis B virus DNA of subtype adr and its conserved gene organization.

Authors:  M Kobayashi; K Koike
Journal:  Gene       Date:  1984-10       Impact factor: 3.688

10.  The complete nucleotide sequences of the cloned hepatitis B virus DNA; subtype adr and adw.

Authors:  Y Ono; H Onda; R Sasada; K Igarashi; Y Sugino; K Nishioka
Journal:  Nucleic Acids Res       Date:  1983-03-25       Impact factor: 16.971

View more
  36 in total

1.  Increased growth of permanent mouse fibroblasts in soft agar after transfection with hepatitis B virus DNA.

Authors:  M Seifer; W H Gerlich
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

Review 2.  Clinical aspects and epidemiology of hepatitis B and C viruses in hepatocellular carcinoma in Japan.

Authors:  K Kiyosawa; S Furuta
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

3.  Detection of a hepatitis B virus variant with a truncated X gene and enhancer II.

Authors:  R Repp; C Keller; A Borkhardt; A Csecke; S Schaefer; W H Gerlich; F Lampert
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

4.  Diversity of hepatitis B virus X gene-related transcripts in hepatocellular carcinoma: a novel polyadenylation site on viral DNA.

Authors:  C Hilger; I Velhagen; H Zentgraf; C H Schröder
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

Review 5.  Hepatocellular carcinoma.

Authors:  Marie-Annick Buendia; Christine Neuveut
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-02       Impact factor: 6.915

6.  Frequent amplification of c-myc in ground squirrel liver tumors associated with past or ongoing infection with a hepadnavirus.

Authors:  C Transy; G Fourel; W S Robinson; P Tiollais; P L Marion; M A Buendia
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

7.  Integrated hepatitis B virus DNA preserves the binding sequence of transcription factor Yin and Yang 1 at the virus-cell junction.

Authors:  M Nakanishi-Matsui; Y Hayashi; Y Kitamura; K Koike
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

8.  Integrated structures of HBV DNA in chronic hepatitis and hepatoma tissues.

Authors:  S Takada; Y Gotoh; S Hayashi; M Kobayashi; K Koike
Journal:  Gastroenterol Jpn       Date:  1990-09

9.  XAP2, a novel hepatitis B virus X-associated protein that inhibits X transactivation.

Authors:  N Kuzhandaivelu; Y S Cong; C Inouye; W M Yang; E Seto
Journal:  Nucleic Acids Res       Date:  1996-12-01       Impact factor: 16.971

10.  A truncated mutant (residues 58-140) of the hepatitis B virus X protein retains transactivation function.

Authors:  V Kumar; N Jayasuryan; R Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.